Steven Armstrong
Chief Operating Officer chez LEXAGENE HOLDINGS INC.
Fortune : 73 216 $ au 31/01/2023
Profil
Steven Armstrong is currently the Chief Operating Officer at Lexagene Holdings, Inc. He previously held positions as the Senior Vice President-Operations at Palomar Medical Technologies LLC and as the Vice President-Operations at ConforMIS, Inc. Additionally, he had a brief tenure at Dibb Lupton Broomhead.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LEXAGENE HOLDINGS INC.
0,28% | 19/12/2022 | 397 911 ( 0,28% ) | 73 216 $ | 31/01/2023 |
Postes actifs de Steven Armstrong
| Sociétés | Poste | Début |
|---|---|---|
| LEXAGENE HOLDINGS INC. | Chief Operating Officer | 24/03/2020 |
Anciens postes connus de Steven Armstrong
| Sociétés | Poste | Fin |
|---|---|---|
| CONFORMIS, INC. | Corporate Officer/Principal | - |
| PALOMAR MEDICAL TECHNOLOGIES INC | Chief Operating Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CONFORMIS, INC. | Health Technology |
| LEXAGENE HOLDINGS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Palomar Medical Technologies LLC
 Palomar Medical Technologies LLC Electronic ComponentsElectronic Technology Palomar Medical Technologies LLC engages in the research, development, manufacturing and distribution of light based systems for cosmetic treatments. The company is involved in developing a differentiated product mix of light-based systems for various treatments through its research and development as well as with its partnerships throughout the world. It is continually developing and testing new indications to further the advancement in light-based treatments. The company operates through two segments: Professional Product and Consumer Product. The Professional Product segment includes all of its light-based products and services for the professional market. The Consumer Product segment includes PaloVia. It offers products based on technologies that include hair removal, body sculpting, including laser-assisted liposuction, removal of vascular lesions such as rosacea, spider veins, port wine stains and hemangiomas, wrinkle reduction, removal of leg veins, removal of benign pigmented lesions such as age and sun spots, freckles and melasma, tattoo removal, acne treatment, skin resurfacing, treatment of red pigmentation in hypertrophic and keloid scars, treatment of verrucae, skin tags, seborrheic keratosis, skin tightening through soft tissue coagulation, removal of scars, including acne scars, stretch marks and warts and soft tissue coagulation. Palomar Medical Technologies was founded in 1987 and is headquartered in Burlington, MA. | Electronic Technology |
